Bruckner H - Search Results

1

Stereotactic radiosurgery plays a critical role in enhancing long-term survival in a patient with pancreatic cancer metastatic to the brain.

Rajappa P, Margetis K, Wernicke G, Ginter P, Cope W, Sherr DL, Lavi E, Fine RL, Schwartz TH, Bruckner H, Pannullo SC. Rajappa P, et al. Among authors: bruckner h. Anticancer Res. 2013 Sep;33(9):3899-903. Anticancer Res. 2013. PMID: 24023326

2

Targeted Therapy for Resistant Cholangiocarcinoma with Bevacizumab or Cetuximab Added to Failed Cytotoxic Drug Cores.

Bruckner HW, Hirschfeld A, Schwartz M. Bruckner HW, et al. Anticancer Res. 2016 Jan;36(1):399-402. Anticancer Res. 2016. PMID: 26722072

3

Bevacizumab as treatment for chemotherapy-resistant pancreatic cancer.

Bruckner HW, Hrehorovich VR, Sawhney HS. Bruckner HW, et al. Anticancer Res. 2005 Sep-Oct;25(5):3637-9. Anticancer Res. 2005. PMID: 16101193 Free article.

4

Bevacizumab Added to Moderate-dose Chemotherapy for Refractory Uterine Cancer.

Bruckner HW, Gurell D, Hirschfeld A. Bruckner HW, et al. Anticancer Res. 2018 Jan;38(1):547-552. doi: 10.21873/anticanres.12257. Anticancer Res. 2018. PMID: 29277822

5

Leucovorin and 5-fluorouracil as a treatment for disseminated cancer of the pancreas and unknown primary tumors.

Bruckner HW, Crown J, McKenna A, Hart R. Bruckner HW, et al. Cancer Res. 1988 Oct 1;48(19):5570-2. Cancer Res. 1988. PMID: 3046742 Clinical Trial.

6

Survival after combined modality therapy for pancreatic cancer.

Bruckner HW, Kalnicki S, Dalton J, Snady H, Schwartz GK, Chesser MR, Lehrer D, Mandeli J, Harpaz N, Janus C. Bruckner HW, et al. J Clin Gastroenterol. 1993 Apr;16(3):199-203. doi: 10.1097/00004836-199304000-00006. J Clin Gastroenterol. 1993. PMID: 8505490 Clinical Trial.

7

Long-term follow-up of twenty patients with adenocarcinoma of the pancreas: resection following combined modality therapy.

Cooperman AM, Snady H, Bruckner HW, Hammerman H, Siegel J, Stark B, Bank S. Cooperman AM, et al. Among authors: bruckner hw. Surg Clin North Am. 2001 Jun;81(3):699-708. doi: 10.1016/s0039-6109(05)70155-9. Surg Clin North Am. 2001. PMID: 11459283

8

Taxol inhibits growth of mesothelioma xenografts.

Lee JM, Bruckner HW, Szrajer L, Brenne U, Schindelheim G, Andreotti PE. Lee JM, et al. Among authors: bruckner hw. Anticancer Res. 1995 May-Jun;15(3):693-6. Anticancer Res. 1995. PMID: 7645945

9

Survival advantage of combined chemoradiotherapy compared with resection as the initial treatment of patients with regional pancreatic carcinoma. An outcomes trial.

Snady H, Bruckner H, Cooperman A, Paradiso J, Kiefer L. Snady H, et al. Among authors: bruckner h. Cancer. 2000 Jul 15;89(2):314-27. doi: 10.1002/1097-0142(20000715)89:2<314::aid-cncr16>3.0.co;2-v. Cancer. 2000. PMID: 10918161 Clinical Trial.

10

Irinotecan combined with gemcitabine, 5-fluorouracil, leucovorin, and cisplatin (G-FLIP) is an effective and noncrossresistant treatment for chemotherapy refractory metastatic pancreatic cancer.

Kozuch P, Grossbard ML, Barzdins A, Araneo M, Robin A, Frager D, Homel P, Marino J, DeGregorio P, Bruckner HW. Kozuch P, et al. Among authors: bruckner hw. Oncologist. 2001;6(6):488-95. doi: 10.1634/theoncologist.6-6-488. Oncologist. 2001. PMID: 11743211 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

368 results

Search Page